Adverse drug reactions in Nigerian children

Paediatric and Perinatal Drug Therapy

Volumn 8, Issue 2, 2007, Pages 81-88

  Oshikoya, K A ^a,b   Njokanma, O F ^b   Chukwura, H A ^b   Ojo, I O ^b  

^a LAGOS STATE UNIVERSITY   (Nigeria)

^b LAGOS STATE UNIVERSITY TEACHING HOSPITAL   (Nigeria)

Author keywords

Adverse drug reactions; Antibiotics; Children; Skin reactions

Indexed keywords

AMPICILLIN; AMPICILLIN PLUS CLOXACILLIN; ANTIBIOTIC AGENT; ARTESUNATE; CALAMINE; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CHLORAMPHENICOL; CHLOROQUINE; CORTICOSTEROID; COTRIMOXAZOLE; DEXAMETHASONE; FANSIDAR; GENTAMICIN; HALOFANTRINE; HERBACEOUS AGENT; ISONIAZID; METOCLOPRAMIDE; MINERAL OIL; MULTIVITAMIN; PARACETAMOL; PHENOBARBITAL; PROCAINE PENICILLIN; PROMETHAZINE; PYRAZINAMIDE; QUININE; RIFAMPICIN; UNINDEXED DRUG; VANCOMYCIN;

ANAPHYLAXIS; ARTICLE; AWARENESS; BEHAVIOR DISORDER; BRAIN MALARIA; CONVULSION; DEVELOPING COUNTRY; DIARRHEA; DRUG FATALITY; DRUG MONITORING; DRUG SURVEILLANCE PROGRAM; DYSTONIA; ERYTHEMA MULTIFORME; FEMALE; FEVER; FIXED DRUG ERUPTION; GASTROENTERITIS; HEALTH PRACTITIONER; HEMORRHOID; HEPATIC ENCEPHALOPATHY; HOSPITALIZATION; HUMAN; HYPERBILIRUBINEMIA; INFANT; JAUNDICE; LIVER FAILURE; LOTION; MACULAR RASH; MAJOR CLINICAL STUDY; MALARIA; MALE; MEASLES; MEDICAL RECORD; MENINGITIS; MONITORING; MORBILIFORM RASH; NEWBORN; NIGERIA; PAPULONODULAR RASH; PERINATAL ASPHYXIA; POLYPHARMACY; PRESCHOOL CHILD; PRESCRIPTION; PROSPECTIVE STUDY; PUBLIC HEALTH PROBLEM; PUSTULE; RASH; RED MAN SYNDROME; RETROSPECTIVE STUDY; RISK REDUCTION; SCHOOL CHILD; SEPSIS; SEPTICEMIA; SKIN MANIFESTATION; STEVENS JOHNSON SYNDROME; TONSILLITIS; TRANSITIONAL BLINDNESS; TUBERCULOUS MENINGITIS; TYPHOID FEVER; URINARY TRACT INFECTION; URTICARIA; WARD;

EID: 35448959171     PISSN: 14630095     EISSN: None     Source Type: Journal    
DOI: 10.1185/146300907X199858     Document Type: Article

References (50)

1. Pirmohamed M, Park BK. Adverse drug reactions: back to the future. Br J Clin Pharmacol. 2003;55: 486-492.
2. Dorman H, Muth-Selbach U, Krebs S, et al. Incidence and costs of adverse drug reactions during hospitalization: computerized monitoring versus stimulated spontaneous reporting. Drug Saf 2000;25:161-168.
3. Rieder M. Adverse drug reactions. The Canadian Journal of CME. 2002;83-91.
4. Institute of Medicine (US). To err is human: Building a Safer health system. Kohn LT, Corrigan JM, Donaldson MS, eds. Washington: The Institute; 2000.
5. Fletcher AP. Spontaneous adverse drug reporting vs event monitoring: a comparison. J R Soc Med 1991;84:341-344.
6. Jonville-Bera AP, Giraudeau B, Blanc P, Beau-Salinas F, Autret-Leca E. Frequency of adverse drug reactions in children: a prospective study. Br J Clin Pharmacol 2002;53:207-210.
7. Weiss J, Krebs S, Hoffmann C et al. Survey of adverse drug reactions on paediatric ward: a strategy for early detailed detection. Pediatrics 2002;110: 254-257.
8. Pirmohamed M. Anticipating, investigating and managing the adverse effects of drugs. Clin Med 2005;5:23-25.
9. Impicciatore P, Choonara I, Clarkson A, Provasi D, Pandolfini C, Bonati M. Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies. Br J Clin Pharmacol 2001;52:77-83.
10. Clarkson A, Ingleby E, Choonara I, Bryan P, Arlett P. A novel scheme for the reporting of adverse drug reactions. Arch Dis Child 2001;84:337-339.
11. Kemp A, Singh-Grewal D, Wong M. A prospective study of the immediate and delayed adverse events following intravenous immunoglobulin infusions. Arch Dis Child 2006;91:651-654.
12. Le J, Nguyen T, Law AV, Hodding J. Adverse drug reactions among children over a 10- year period. Pediatrics 2006;118:555-562.
13. Olayemi SO, Oreagba I, Onajole AT, Ajekigbe AT. Antimicrobial prescription patterns in urban and rural primary health facilities in South Western Nigeria. Nig Med Pract 2005;47:82-86.
14. Nwolisa CE, Erinaugha EU, Ofoleta SI, 2006. Prescribing practices of doctors attending to under fives in a children's outpatient clinic in Owerri, Nigeria. J Trop Paediatr 2006;52:197-200.
15. Oshikoya KA, Chukwura HA, Ojo IO. Evaluation of outpatient paediatric drug prescriptions in a teaching hospital in Nigeria for rational prescription Paed Perinat Drug Ther 2006;7:183-188.
16. Rawlins MD, Thompson JW. Mechanisms of adverse drug reactions. In: Davies DM. Ed. Textbook of adverse drug reactions. Oxford: Oxford University Press, 1991:18-45.
17. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998;279:1200-1205.
18. Clarkson A, Conroy S, Burroughs K, Choonara I. Surveillance for adverse drug reactions in children: a paediatric regional monitoring centre. Paed Perinatal Drug Ther 2004;6:20-23.
19. Pouyanne P, Haramburu F, Imbs JL, Begaud B. Admissions to hospital caused by adverse drug reactions: cross-sectional incidence study. French Pharmacovigilance Centres. Br Med J 2000;320:1036.
20. Hallas J, Harvard B, Gram LF, et al. Drug related hospital admissions: the role of definitions and intensity of data collection and possibility of prevention. J Intern Med 1990;228:83-90.
21. Sule SS. Childhood morbidity and treatment pattern at the multipurpose health centre Ilesa, Nigeria. Niger J Med 2003;12:145-149.
22. Ansah EK, Gyapong JO, Agyepong IA, Evan DB. Improving adherence to malaria treatment for children: the use of pre-packed chloroquine tablets vs. chloroquine syrup. Trop Med Int Health 1996;6:496-504.
23. Ajayi IO, Falade CO. Pre-hospital treatment of febrile illness in children attending the general outpatients' clinic, University College Hospital, Ibadan, Nigeria. Afr J Med Sci 2006;35:85-91.
24. Fawole O, Onadeko MO. Knowledge and home management of malaria fever by mothers and caregivers for under-five children. West Afr J Med 2001;20:152-157.
25. Igba I, Pervez S, Baig S. Management of children with acute respiratory infection (ARI) by general practitioners in Multan- an observational study. Pak Med Assoc 1997;47:24-28.
26. Ohaju-Obodo JO, Isah AO, Mabadeje AFB. Prescribing patterns of clinicians in private health institutions in Edo and Delta States of Nigeria. Nig Quart J Hosp Med 1998;8:91-94.
27. Odusanya, OO, Oyediran MA. Rational drug use at the primary health care centres in Lagos, Nigeria. Nigerian Quart J Hosp Med 2000;10:4-7.
28. Akinyede AA, Mabadeje AFB, Aliu MO. A comparative study of patterns of prescription of antibiotics in two health centres in Lagos. J Nig Infect Cont Assoc 2000;3:20-3.
29. Oshikoya KA. Antimalarial prescriptions for children presenting with uncomplicated malaria to a teaching hospital in Nigeria after the change of national guidelines for malaria treatment. World J Med Sci 2007;2:49-53.
30. Oshikoya KA, Njokanma F. Adverse drug reactions in children: a review of management. Int J Pharmacol 2007;3:11-18.
31. Oshikoya KA. Adverse drug reactions in children: types, incidence, and risk factors. Nig J Paed. 2007 (In press).
32. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356:1255-1259.
33. World Health Organization Collaborating Center for International Drug Monitoring of Adverse Reaction Terminology. Uppsala, Switzerland: the Uppsala Monitoring Centre; 2002.
34. Jones JK. Adverse drug reactions in the community health setting: approaches to recognizing, counselling, and reporting. Fam Community Health 1982;5:58-67.
35. Schirm E, Tobi H, van Puijenbroek EP, Monster-Simons MH, de Jong-van den Berg LT. Reported adverse drug reactions and their determinants in Dutch children outside the hospital. Pharmacoepidemiol Drug Saf 2004;13:159-165.
36. Martinez-Mir I, Garcia-LopezM, Palop V, Ferrer JM, Rubio E, Morales-Olivas FJ. A prospective study of adverse drug reactions in hospitalized children. Br J Clin Pharmacol 1999;47:681-688.
37. Martinez-Mir I, Garcia-Lopez M, Palop V, et al. A prospective study of adverse drug reactions as a cause of admission to a paediatric hospital. Br J Clin Pharmacol. 1996;42:319-324.
38. Vargas E, Terleira A, Hernando F, et al. Effect of adverse drug reactions on length of stay in surgical intensive care units. Crit Care Med 2003;31: 694-698
39. Einarson T. Drug related hospital admissions. Ann Pharmacother. 1993;27:832-840.
40. Fattinger K, Roos M, Vergeres P, et al. Epidemiology of drug exposure adverse drug reactions in two Swiss departments of Internal Medicine. Br J Clin Pharmacol. 2000;49:158-167.
41. Pirmohammed M, James S, Meakin S et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients BMJ 2004;329:15-19.
42. Fattahi F, Pourpak Z, Moin M et al. Adverse drug reactions in hospitalized children in a department of infectious diseases. J Clin Pharmacol 2005;45: 1313-1318.
43. Cirko-Begovic A, Vrhovac B, Bakran I. Intensive monitoring of adverse drug reactions in infants and preschool children. Eur J Clin Pharmacol. 1989;36:63-65.
44. Kramer MS, Hutchinson TA, Flegel KM, Naimark L, Contardi R, Leduc DG. Adverse drug reactions in general paediatric outpatients. J Pediatr 1985;106:305-310.
45. Taketomo CK, Hodding JH, Kraus DM. Pediatric Dosage Handbook. 11th edition, Lexi-Comp Inc., Ohio. 2004.
46. Luyckx VA, Steenkamp V, Rubel JR, Stewart MJ. Adverse effects associated with the use of South African traditional folk remedies. Cent Afr J Med. 2004;50:46-51.
47. Mofenson HC, Caraccio TR. Toxicity of household products. In: Viccellio P. Ed. Emergency Toxicology 2nd Ed. Lippincott-Raven Publishers, 1998:487-491.
48. Gonzalenz-Martin G, Caroca CM, Paris E. Adverse drug reactions (ADRs) in hospitalised paediatric patients. Int J Gin Pharmacol Ther 1998;36: 530-533.
49. Turner S, Nunn AJ, Fielding K, Choonara I. Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study. Acta Paediatrica 1995;84:965-968.
50. Kidon MI, See Y. Adverse drug reactions in Singaporean Children. Singapore Med J 2004;45:574-577.